May 9, 2012 / 5:15 AM / 7 years ago

Germany's Bayer considers diabetes device unit sale: report

The logo of Germany's largest drugmaker Bayer HealthCare Pharmaceuticals is pictured on the front of its building in Berlin April 28, 2011. REUTERS/Fabrizio Bensch

FRANKFURT (Reuters) - Germany’s largest drugmaker Bayer is considering the sale of its blood glucose meters business, a German newspaper reported.

Bayer has held talks with prospective buyers of its Diabetes Care unit, which has annual sales of about 1 billion euros ($1.3 billion), Financial Times Deutschland said in its Wednesday edition, citing sources close to the possible suitors and in the financial industry.

The paper said that Bayer declined to comment.

($1 = 0.7695 euros)

Reporting by Ludwig Burger; Editing by Ed Lane

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below